Join us for an exciting week of educational content, being released online each day at 6pm ET of our 2021 Spring Clinical Lipid Update On-Demand. We will provide many exciting sessions and topics, including the challenges that lipid specialists face during and after COVID, challenging patient cases and complex pharmacotherapy. You will have the opportunity to ask your questions of the expert faculty in our scheduled Twitter Chats that will be held after each session at 1pm the following day. This content will be available free of charge and open access to all. Please scroll down to the Agenda to view the topics that will be presented.

Please note: You do not need to register for the 2021 Spring Clinical Lipid Update to access the content.  If you are interested in taking part in our Foundations of Lipidology or Masters of Lipidology virtual, live courses taking place in early March, please register at the bottom of this page.

You may need to disable administrative overlay in your Drupal record


Target Audience
This activity is designed to meet the needs of physicians, physician assistants, pharmacists, registered nurses, nurse practitioners, advance practice registered nurses, and registered dietitians with an interest in lipid management.

Type of Activity
Enduring Internet Activity

Educational Objectives

At the conclusion of this activity, all participants should be able to:

  • Discuss strategies to improve the knowledge, skills or performance of the healthcare team;

Session: Challenges for the Lipid Specialist During and After COVID

  • Discuss efficient models of patient care, including operational issues, regulations, and referral strategies to run successful lipid clinics in various settings.
  • Determine opportunities for ensuring patients are well informed about treatment options for Dyslipidemia.

Session: Lipid Logic- Diet Edition- Challenging Patient Cases

  • Outline the impact of various diets on cardiovascular risks.

Session: Tackling Residual ASCVD Risk: Beyond Statin Therapy

  • Discuss the implications of novel therapies in development for the future atherosclerotic cardiovascular disease risk reduction.
  • Assess the implications of recent outcomes trials for the clinical management of patients with diabetes.
  • Discuss the implications of novel approaches for the clinical management of patients with at high cardiovascular risk.

Session: Complex Pharmacotherapy in Lipidology

  • Discuss potential drug-drug interactions in special populations.
  • Describe the appropriate usage of pharmacotherapeutics in patients who need additional LDL cholesterol lowering.

Session: Severe Hypertriglyceridemia

  • Summarize the evidence-based recommendations for the treatment of patients with severe hypertriglyceridemia.
  • Discuss the implications of current and pipeline therapies for the clinical management of patients with dyslipidemia.
  • Outline the impact of various diets for the management of severe hypertriglyceridemia.
  • Discuss treatment options for the management of patients with severe hypertriglyceridemia.

Edit Parent - PROGRAM (visibility Show)


PLEASE NOTE: You do not need to register for any of the sessions listed below.  They will be provided free of charge and open access to all. Please make plans to access each content drop at 6pm ET on each of the days listed below. 

Monday, February 22
Session - Challenges for the Lipid Specialist During and After COVID
Your Lipid Specialist Will See Now - Virtually
Nicole Ciffone, ANP-C, CLS, FNLA
Who do you need in a 2021 Lipid Clinic? Who is the Team you Need?
James A. Underberg, MD, MS, FNLA
Improving the Challenge of the Clinician - Patient Risk Discussion
Neil J. Stone, MD, FNLA
Tuesday, February 23
Twitter Chat: Challenges for the Lipid Specialist During and After COVID 
#NLATwitter Chat
Session - Lipid Logic - Diet Edition - Challenging Patient Cases
Lifestyle Modification Case
Lynne T. Braun, PhD, NP, CLS, FNLA
Hold the Meat, Pass the Fruits, Vegetables and Legumes: Healthy Plant-Based Dietary Pattern
Kathy Rhodes, PhD, RDN
Hold the Carbs, Pass the Fat versus Hold the Carbs, Pass the Protein
Diane D. Stadler, PhD, RD, LD
Pass the Fruits, Vegetables, Nuts, Fish and EVOO, Hold the Red Meat; Mediterranean Dietary Pattern
Connie Diekman, M.Ed., RD, CSSD, LD
Wednesday, February 24
Twitter Chat: Nutrition in Dyslipidemia and ASCVD Management
Session - Tackling Residual ASCVD Risk: Beyond Statin Therapy
Everything Old is New Again: Inflammation and ASCVD Risk
Samia Mora, MD, MHS
It’s Much More than Just Glucose Lowering in Diabetes: Role of SGLT2i and GLP1-RAs in ASCVD Risk Reduction
Kathleen L. Wyne, MD, FNLA
Managing Infection: Influenza Vaccination in Cardiovascular Risk Reduction
Kevin C. Maki, PhD, CLS, FNLA
Thursday, February 25
Twitter Chat: Tackling Residual ASCVD Risk: Beyond Statin Therapy
Session - Complex Pharmacotherapy in Lipidology
Managing the High-Risk Pharmacological Patient – Traversing Drug-Induced Dyslipidemia and Drug-Drug Interactions among Solid Organ Transplant Patients
Bruce A. Warden, PharmD, CLS, FNLA
LDL Lowering Beyond Statins – Choosing the Right Strategy for the Right Patient
Sheila L. Stadler, PharmD, CLS
Friday, February 26
Twitter Chat: Complex Pharmacotherapy in Lipidology

Exploring the Systems of Care in ASCVD Management: A Healthcare Industry Virtual Panel Discussion from the NLA

2:00 - 3:00 PM ET


Laney Jones, PharmD, MPH  | Kaye-Eileen Willard, MD, FNLA  |  Dean G. Karalis, MD, FNLA

Session - Severe Hypertriglyceridemia
Case Presentation Daniel E. Soffer, MD, FNLA
Pharmacotherapy (Current and Pipeline Medications) Allison Hester, PharmD
Diet Management Lauren Williams, MCN, RD, LD
Management of Severe Multifactorial Hypertriglyceridemia in Patients Without Pancreatitis P. Barton Duell, MD, FNLA
Saturday, February 27
Twitter Chat: Severe Hypertriglyceridemia



Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 5.50 AMA PRA Category 1 Credits™ MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

In support of improving patient care, The National Lipid Association is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Physician Credit Designation Statement
The National Lipid Association designates this enduring internet activity for a maximum of 5.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physician Assistants
NCCPA accepts AMA PRA Category 1 Credits™ from organizations accredited by the ACCME.

The National Lipid Association is a Continuing Professional Education (CPE) Accredited Provider with the Commission on Dietetic Registration (CDR). Registered dietitians (RDs) and dietetic technicians, registered (DTRs) will receive 5.50 continuing professional education units (CPEUs) for completion of this program/ materials. CDR Accredited Provider #NL002.


Pharmacist Accreditation Statement

Universal Activity Number JA0007192-0000-21-001-H01-P (Application)
This Activity has been approved for 5.50 contact hour(s) (5.5 CEUs) of the Accreditation Council for Pharmacy Education

The maximum number of hours awarded for this CE activity is 5.3 contact hours.
For the advanced practice nurse, pharmacotherapy contact hours will be determined on your certificate.

Statements of credit will be awarded based on the participant’s attendance and submission of the activity evaluation form. Partial credit may be awarded for ACPE credit.  A statement of credit will be available upon completion of an online evaluation/claimed credit form at The deadline to claim credit is March 29, 2021.

For Pharmacists: Upon receipt of the completed activity evaluation form, transcript information will be available at within 4 weeks.

Pharmacists MUST request credit before April 16, 2021. Credit requested after this date will be subject to a fee.

For Dietitians: Upon completion of the activity evaluation form, dietitians may submit evaluations of the quality of activities/materials to CDR. Poor evaluations of activities/materials may trigger an audit of the activities/ materials by CDR.

Commercial Support:
This activity is supported by educational funding provided by Akcea Therapeutics and Novartis Pharmaceuticals Corporation.




The following events are independent presentations held in conjunction with the NLA 2021 Spring Clinical Lipid Update On-Demand. They are not part of the official sessions as planned by the NLA Scientific Meetings Committee and are not offered for CME/CE credit.

Edit Parent - LIVE EVENTS (visibility Show)


Friday, February 26 • 2:00 - 3:00 pm ET


Exploring the Systems of Care in ASCVD Management, a healthcare industry virtual panel discussion from the National Lipid Association


Join the National Lipid Association for a special panel discussion on systems of care in the management of atherosclerotic cardiovascular disease (ASCVD) in the United States on Friday, February 26th at 2:00 – 3:00pm Eastern. You will hear from clinicians, health system administrators, payers, and U.S. health agency representatives as they discuss:


·       Barriers to prioritizing ASCVD risk mitigation

  • Lipid quality measures

  • Impact of insurance benefit design

·       Dyslipidemia Management in the Medicare Cohort

·       Development of quality reports and other EHR-based lipid management tools


Join the discussion by tuning in live and sharing your questions for the panelists:


Janice Litza, MD
Vice President Medical Affairs
Ascension All Saints Hospital


Kristin McManmon, FACHE
Regional President
Ascension - All Saints, Franklin and St. Francis Hospitals


Steven Farmer, MD, PhD
Chief Strategy Officer
Coverage and Analysis Group
Center for Clinical Standards and Quality, CMS


Steven K. Kulick, MD, FACEP
Chief Medical Officer, Medicare & Retirement, Wisconsin-Michigan


Kaye-Eileen Willard, MD, FNLA
Ascension Healthcare SE Wisconsin


Laney Jones, PharmD, MPH
Geisinger Commonwealth School of Medicine
Precision Health Center


Dean G. Karalis, MD, FNLA
Thomas Jefferson University Hospital


Richard A. Birnbaum, MD, FACC
Senior Attending Physician
Kaiser Permanente Northern California Regional Genetics Lipid Clinic
Director, Kaiser Permanente Northern California Hypercholesterolemia Program


Karen Aspry, MD, MS, FACC, FAHA, FNLA - Moderator
Prevention Program
Lifespan Cardiovascular Institute
Associate Professor of Medicine
Brown University Alpert Medical School


Sponsored by Amgen, Esperion, Novartis, and Pfizer. 



Thursday, February 25 • 5:00 - 5:50 pm ET


Now Approved: EVKEEZA™ Product Overview

Speaker: Seth J. Baum, MD, FACC, FAHA, FNLA, FASPC 

Hosted by Regeneron


Friday, February 26 • 5:00 - 5:50 pm ET


Help Your Recent MI Patients Achieve Lower LDL-C and Reduce the Risk of Another MI 

Speaker: Alan S. Brown, MD FACC FAHA FNLA FASPC

Join Dr. Alan Brown for an educational presentation on the treatment of very high-risk ASCVD patients described in the 2018 ACC/AHA Guidelines on the Management of Blood Cholesterol. Hear about his experience and the treatment options available for appropriate patients. 


Hosted by Amgen


Edit Parent - ENGAGE (visibility Hide)


The National Lipid Association would like to acknowledge the following Industry Council Members for their support of our overall educational mission and goals for 2021:

  • Akcea Therapeutics
  • Alexion
  • Amarin Pharma Inc.
  • Amgen
  • Amryt Pharma
  • Esperion Therapeutics
  • Novartis
  • Pfizer
  • Regeneron


Lipid Bucks: Lipid Bucks can be applied on the checkout page.

Registration: Online registration and payment must be received no later than February 28, 2020. By registering for this meeting, attendee understands and agrees that attendee’s name, city, and state may be shared with other attendees and exhibitors. By visiting the exhibit hall, attendee understands, agrees and consents to the sharing of attendee’s contact information with the participating companies.

Photography: Photographs and/or video may be taken as part of the registered event. By registering for this event, you grant the National Lipid Association full rights to use the images resulting from the photography/video filming and any reproductions or adaptations of the images for promotional purposes. This may include (but is not limited to), the right to use them in print and online platforms, social media, press releases and other outlets.

Cancellation: Telephone cancellations will not be accepted. A written notice of cancellation must be received no later than January 28, 2020. There will be a $50 fee for all cancellations. There will be no refunds if cancelling within 30 days of the start of the meeting date.

Attendees who need special reasonable accommodations or who have special needs should contact the meeting organizers at 904-998-0854.